Haleon Uk Finance (usd) Limited WEYBRIDGE


Founded in 2016, Haleon Uk Finance (usd), classified under reg no. 10312084 is an active company. Currently registered at Building 5, First Floor KT13 0NY, Weybridge the company has been in the business for 8 years. Its financial year was closed on December 31 and its latest financial statement was filed on 31st December 2022. Since 16th June 2023 Haleon Uk Finance (usd) Limited is no longer carrying the name Glaxosmithkline Consumer Healthcare Finance No. 2.

The firm has 2 directors, namely Michael R., Sajid M.. Of them, Michael R., Sajid M. have been with the company the longest, being appointed on 4 March 2022. As of 28 May 2024, there were 9 ex directors - Mariano G., Hanief A. and others listed below. There were no ex secretaries.

Haleon Uk Finance (usd) Limited Address / Contact

Office Address Building 5, First Floor
Office Address2 The Heights
Town Weybridge
Post code KT13 0NY
Country of origin United Kingdom

Company Information / Profile

Registration Number 10312084
Date of Incorporation Thu, 4th Aug 2016
Industry Financial intermediation not elsewhere classified
End of financial Year 31st December
Company age 8 years old
Account next due date Mon, 30th Sep 2024 (125 days left)
Account last made up date Sat, 31st Dec 2022
Next confirmation statement due date Fri, 7th Jun 2024 (2024-06-07)
Last confirmation statement dated Wed, 24th May 2023

Company staff

Haleon Uk Corporate Secretary Limited

Position: Corporate Secretary

Appointed: 06 April 2022

Haleon Uk Corporate Secretary Limited

Position: Corporate Director

Appointed: 06 April 2022

Haleon Uk Corporate Director Limited

Position: Corporate Director

Appointed: 06 April 2022

Michael R.

Position: Director

Appointed: 04 March 2022

Sajid M.

Position: Director

Appointed: 04 March 2022

Mariano G.

Position: Director

Appointed: 22 June 2021

Resigned: 04 March 2022

Hanief A.

Position: Director

Appointed: 10 March 2020

Resigned: 18 June 2021

Nicholas C.

Position: Director

Appointed: 11 September 2019

Resigned: 04 March 2022

Antrinkos A.

Position: Director

Appointed: 19 August 2019

Resigned: 10 March 2020

Eugene P.

Position: Director

Appointed: 18 March 2019

Resigned: 10 March 2020

Tobias H.

Position: Director

Appointed: 15 January 2019

Resigned: 10 March 2020

Melanie F.

Position: Director

Appointed: 04 August 2016

Resigned: 15 January 2019

Jonathan B.

Position: Director

Appointed: 04 August 2016

Resigned: 30 November 2017

The Wellcome Foundation Limited

Position: Corporate Director

Appointed: 04 August 2016

Resigned: 06 April 2022

Edinburgh Pharmaceutical Industries Limited

Position: Corporate Secretary

Appointed: 04 August 2016

Resigned: 06 April 2022

Glaxo Group Limited

Position: Corporate Director

Appointed: 04 August 2016

Resigned: 06 April 2022

Richard G.

Position: Director

Appointed: 04 August 2016

Resigned: 10 March 2020

People with significant control

The list of persons with significant control who own or have control over the company is made up of 1 name. As we established, there is Haleon Uk Services Limited from Weybridge, England. This PSC is categorised as "an english", has 75,01-100% voting rights and has 75,01-100% shares. This PSC has 75,01-100% voting rights and has 75,01-100% shares.

Haleon Uk Services Limited

Building 5 First Floor, The Heights, Weybridge, Surrey, KT13 0NY, England

Legal authority Corporate
Legal form English
Country registered United Kingdom
Place registered Companies House
Registration number 09237639
Notified on 4 August 2016
Nature of control: 75,01-100% shares
75,01-100% voting rights
right to appoint and remove directors

Company previous names

Glaxosmithkline Consumer Healthcare Finance No. 2 June 16, 2023

Company filings

Filing category
Accounts Address Capital Change of name Confirmation statement Incorporation Insolvency Officers Persons with significant control Resolution
Change to a person with significant control 18th July 2022
filed on: 7th, November 2023
Free Download (2 pages)

Company search